A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical–chemical risk factors of cardiovascular disease in a primary care setting

By Schuitemaker G.E.   van der Pol G.A.   Aretz C.P.M.   Dinant G.J.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 857-863

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Inhaled Corticosteroids on Respiratory Function Tests and Airway Inflammation in Stable Chronic Obstructive Pulmonary Disease: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

By Mirici A.  

Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. : 835-842

Adis International

Access to resources Recommend Favorite

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial

By Naber Dieter   Greenspan Andrew   Schreiner Andreas  

Psychopharmacology, Vol. 191, Iss. 4, 2007-05 ,pp. : 1027-1029

Springer Publishing Company

Access to resources Recommend Favorite

Polypill for cardiovascular disease prevention provokes debate

By  

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: the Pivotal Placebo-controlled Clinical Trial

By Insull W   Isaacsohn J   Kwiterovich P   Ma P   Brazg R   Dujovne C   Shan M   Shugrue-Crowley E   Ripa S   Tota R    

The Journal of International Medical Research, Vol. 28, Iss. 2, 2000-03 ,pp. : 47-68

Field House Publishing

Access to resources Recommend Favorite